Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 61 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9573908

    Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted

  2. US 9567348

    Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  3. US 9566278

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted

  4. US 9562056

    Imidazopyridines Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  5. US 9562002

    STAT3 inhibitor

    The Board of Regents of the University of Texas System · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted

  6. US 9555041

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  7. US 9556144

    Compound as WNT signaling inhibitor, composition, and use thereof

    Curegenix, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  8. US 9550756

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  9. US 9546151

    VMAT inhibitory compounds

    The United States of America as represented by the Department of Veteran Affairs · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  10. US 9540337

    Gamma-glutamyl transpeptidase inhibitors and methods of use

    The Board of Regents of the University of Oklahoma · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  11. US 9540415

    Inhibitors of the farnesoid X receptor and uses in medicine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  12. US 9540395

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  13. US 9540427

    Peptide-based stat inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted

  14. US 9533990

    Inhibitors of secretion of hepatitis B virus antigens

    ARBUTUS BIOPHARMA CORPORATION · Granted Jan 3, 2017 · Expires Dec 29, 2036

    granted

  15. US 9526769

    Macrocylic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  16. US 9527878

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  17. US 9527841

    Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  18. US 9527884

    Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use

    The Board of Regents of the University of Oklahoma · Granted Dec 27, 2016 · Expires Dec 22, 2036

    granted

  19. US 9522910

    Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA” · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  20. US 9518040

    GDF-8 inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  21. US 9517230

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  22. US 9518056

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  23. US 9513289

    Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases

    The United Sates of America, as Represented by the Department of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  24. US 9512143

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.